Sequoia Capital, Vertex Ventures join Chinese biotech startup’s $226m series B round By administratorbiotech, Investments, Legend Capital, Lyfe Capital, News, RecBio, Sequoia Capital, Startups, techinasia, Vertex Ventures Part of the funds will be used to conduct clinic tests of HPV 9-valent vaccine and recombinant Covid vaccine. Read More November 11, 2020 Love0
